-
Not a week goes by where I do not see at least one or two newly diagnosed cases of syphilis and not just in my HIV+ MSM patients. Syphilis is beginning to appear in young heterosexuals as well.
-
-
A national survey of parents found that information from the CDC about vaccines and adverse facts may not be effective in correcting parental misperceptions. Some attempts to heighten parental awareness about vaccine-preventable diseases and vaccine safety may actually be counterproductive.
-
Posaconazole oral suspension (Noxafil® oral suspension, Merck) has been, for several years, indicated for treatment of orophayngeal candidiasis as well as for prophylaxis of invasive Aspergillus and Candida infections in patients at risk. Posaconazole delayed-release tablets (Noxafil® delayed-release tablets, Merck) were recently FDA-approved for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients 13 years of age and older.
-
Most children presenting for care related to fever at two Tanzanian outpatient clinics had acute respiratory infections. Malaria accounted for "only" 11% of diagnoses and typhoid fever for 4%.
-
-
-
Historically, men with high-risk prostate cancer were believed to have low survival rates after definitive treatment with either surgery or radiation. However, long-term results of dose-escalated radiotherapy of doses ≥ 75.6 Gy, along with long-term androgen deprivation therapy (ADT), demonstrate 5-year survival rate of 92%, 5-year biochemical control rate of 82%, and symptomatic local failure rate of 0%. Death from prostate cancer was only 5.5% at 10 years in men treated with high-dose radiation therapy and ADT.
-
-
In a study of men in the Veterans Affairs health care system with low serum testosterone levels, the use of testosterone therapy was associated with an increased risk of mortality, myocardial infarction, or ischemic stroke.
